Margaret McGlynn
Director/Board Member at AMICUS THERAPEUTICS, INC.
Net worth: 790 994 $ as of 2024-03-30
Profile
Margaret G.
McGlynn is currently the Chairman & President at HCU Network America, an Independent Director at Novavax, Inc., an Independent Director at Amicus Therapeutics, Inc., a Director at Abington Friends School, a Director at Orphan Technologies Ltd., and a Director at Life Science Cares Philadelphia.
In the past, Ms. McGlynn served as the President, Chief Executive Officer & Director at International AIDS Vaccine Initiative, Inc., an Independent Director at Air Products & Chemicals, Inc., a Director at Quidel Corp., an Independent Director at Vertex Pharmaceuticals, Inc., a Director at GAVI Alliance, and the President-Global Vaccines & Infectious Disease at Merck & Co., Inc. She also held a position as President at the US Department of Health & Human Services (DC).
Ms. McGlynn obtained an undergraduate degree in 1981 and an MBA in 1983 from the State University of New York at Buffalo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-04 | 59,289 ( 0.02% ) | 698 424 $ | 2024-03-30 | |
| 2023-04-30 | 178 ( 0.00% ) | 74 406 $ | 2024-03-30 | |
NOVAVAX, INC.
0.00% | 2023-06-11 | 3,800 ( 0.00% ) | 18 164 $ | 2024-03-30 |
Margaret McGlynn active positions
| Companies | Position | Start |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director/Board Member | 2009-09-30 |
| NOVAVAX, INC. | Director/Board Member | 2020-12-06 |
Abington Friends School
 Abington Friends School Other Consumer ServicesConsumer Services Abington Friends School provides primary and secondary education services. The company was founded in 1697 by John Barnes and is headquartered in Jenkintown, PA. | Director/Board Member | - |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Director/Board Member | 2015-11-30 |
HCU Network America
 HCU Network America Services to the Health IndustryHealth Services HCU Network America provides support services for patients and families. The non-profit company is based in Lisle, IL. | Chairman | 2016-05-31 |
| Life Science Cares Philadelphia | Director/Board Member | - |
Former positions of Margaret McGlynn
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Director/Board Member | 2023-05-16 |
| AIR PRODUCTS & CHEMICALS, INC. | Director/Board Member | 2020-11-22 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Chief Executive Officer | 2015-08-31 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Margaret McGlynn
| State University of New York at Buffalo | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AIR PRODUCTS & CHEMICALS, INC. | Process Industries |
| MERCK & CO., INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NOVAVAX, INC. | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
| GAVI Alliance | Miscellaneous |
| US Department of Health & Human Services (DC) | Government |
Abington Friends School
Abington Friends School Other Consumer ServicesConsumer Services Abington Friends School provides primary and secondary education services. The company was founded in 1697 by John Barnes and is headquartered in Jenkintown, PA. | Consumer Services |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Health Technology |
HCU Network America
HCU Network America Services to the Health IndustryHealth Services HCU Network America provides support services for patients and families. The non-profit company is based in Lisle, IL. | Health Services |
| Life Science Cares Philadelphia |
- Stock Market
- Insiders
- Margaret McGlynn
